Leqembi: European Regulators Approve a New Hope for Alzheimer's Treatment.

Europe has said yes to Leqembi, a new medicine for Alzheimer's. This medicine helps people who are in the early stages of this sickness. The medicine is made by a company from Japan.

At first, some people in Europe did not want to approve the medicine. They were worried about problems that could happen. But later, they looked at it again and said it was okay.

Leqembi helps to clean the brain from a sticky stuff that is linked to Alzheimer's. Studies show that it can make the sickness get worse more slowly. This means people can remember things and think better for a bit longer.

The medicine is for people who have the sticky stuff in their brain and not much of a special gene. This makes it less likely for them to have problems from the medicine. One expert thinks it will take a long time for this medicine to become common in Europe.

There is another medicine like Leqembi, but Europe has said no to it for now. Both medicines have been approved in America. The company that makes the other medicine hopes to talk more about it.